Nanoparticle usage and protection measures in the manufacturing industry--a representative survey.
J Occup Environ Hyg
; 7(4): 224-32, 2010 Apr.
Article
en En
| MEDLINE
| ID: mdl-20155559
ABSTRACT
Addressing the risks of nanoparticles requires knowledge about release into the environment and occupational exposure. However, such information currently is not systematically collected; therefore, this risk assessment lacks quantitative data. The goal was to evaluate the current level of nanoparticle usage in Swiss industry as well as health, safety, and environmental measures, and the number of potentially exposed workers. A representative, stratified mail survey was conducted among 1626 clients of the Swiss National Accident Insurance Fund (SUVA), which insures 80,000 manufacturing firms, representing 84% of all Swiss manufacturing companies (947 companies answered the survey for a 58.3% response rate). The extrapolation to all Swiss manufacturing companies results in 1309 workers (95% confidence interval [CI] 1073 to 1545) potentially exposed to nanoparticles in 586 companies (95% CI 145 to 1027). This corresponds to 0.08% of workers (95% CI 0.06% to 0.09%) and to 0.6% of companies (95% CI 0.2% to 1.1%). The industrial chemistry sector showed the highest percentage of companies using nanoparticles (21.2%). Other important sectors also reported nanoparticles. Personal protection equipment was the predominant protection strategy. Only a few applied specific environmental protection measures. This is the first nationwide representative study on nanoparticle use in the manufacturing sector. The information gained can be used for quantitative risk assessment. It can also help policymakers design strategies to support companies developing a safer use of nanomaterial. Noting the current low use of nanoparticles, there is still time to proactively introduce protective methods. If the predicted "nano-revolution" comes true, now is the time to take action.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Exposición Profesional
/
Nanopartículas
/
Industrias
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
País como asunto:
Europa
Idioma:
En
Año:
2010
Tipo del documento:
Article